Published in Int J Cancer on May 15, 1994
Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs. J Exp Med (1999) 2.13
Interferon lambda: a new sword in cancer immunotherapy. Clin Dev Immunol (2011) 1.04
The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma. J Gastroenterol (2010) 0.86
Interferon-Alpha Promotes Th1 Response and Epithelial Apoptosis via Inflammasome Activation in Human Intestinal Mucosa. Cell Mol Gastroenterol Hepatol (2016) 0.75
The requirement of more than one antigenic determinant for immunogenicity. J Exp Med (1969) 5.61
Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity (2001) 5.04
Enhanced NK cell activity in mice injected with interferon and interferon inducers. Nature (1978) 3.72
Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA. Cell (1990) 3.67
Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med (1976) 3.28
A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med (1974) 3.01
Host gene influences sensitivity to interferon action selectively for influenza virus. Nature (1980) 2.88
Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver. Proc Natl Acad Sci U S A (1996) 2.68
On the varied biologic effects of interferon. Cell Immunol (1977) 2.47
Enhancement by interferon of the specific cytotoxicity of sensitized lymphocytes. Proc Natl Acad Sci U S A (1972) 2.41
Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natl Acad Sci U S A (1978) 2.41
Interferon and cell division. I. Inhibition of the multiplication of mouse leukemia L 1210 cells in vitro by interferon preparations. Proc Natl Acad Sci U S A (1970) 2.37
Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity (1998) 2.22
Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med (1991) 2.16
Genetically determined, interferon-dependent resistance to influenza virus in mice. J Exp Med (1979) 2.14
Interferon inhibits DNA synthesis induced in mouse lymphocyte suspensions by phytohaemagglutinin or by allogeneic cells. Nat New Biol (1972) 2.12
Enhancement by interferon of the expression of surface antigens on murine leukemia L 1210 cells. Proc Natl Acad Sci U S A (1973) 2.11
Pronounced antiviral activity of human interferon on bovine and porcine cells. Nature (1974) 2.10
Antitumor effects of interferon. Biochim Biophys Acta (1978) 2.04
Lymphoma cell-mediated degradation of sulfated proteoglycans in the subendothelial extracellular matrix: relationship to tumor cell metastasis. Cancer Res (1983) 2.04
Relationships between viruses and leucocytes. Prog Med Virol (1966) 2.02
Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow. Nat Med (2001) 1.88
Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells. Proc Natl Acad Sci U S A (1976) 1.88
Metastatic potential severely altered by changes in tumor cell adhesiveness and cell-surface sialylation. J Exp Med (1983) 1.84
Purification of mouse interferon by sequential affinity chromatography on poly(U)--and antibody--agarose columns. Nature (1978) 1.81
Effects of interferon on antibody synthesis in vitro. J Immunol (1974) 1.73
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Interferon and cell division. VI. Inhibitory effect of interferon on the multiplication of mouse embryo and mouse kidney cells in primary cultures. Proc Soc Exp Biol Med (1971) 1.65
Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells. Eur J Immunol (1979) 1.65
Lethality of interferon preparations for newborn mice. Nature (1975) 1.65
The neglected role of type I interferon in the T-cell response: implications for its clinical use. Immunol Today (1996) 1.63
Progressive glomerulonephritis in mice treated with interferon preparations at birth. Nature (1976) 1.59
Inhibition of haemopoietic colony growth by interferon preparations from different sources. Nat New Biol (1973) 1.57
Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proc Natl Acad Sci U S A (1984) 1.56
Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon. J Virol (1994) 1.56
Effect of repeated inoculation of interferon preparations on infection of mice with encephalomyocarditis virus. Proc Soc Exp Biol Med (1968) 1.53
A comparison of the efficacy of endogenous, exogenous, and combined endogenous-exogenous interferon in the treatment of mice infected with encephalomyocarditis virus. Proc Soc Exp Biol Med (1969) 1.52
Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice. Proc Natl Acad Sci U S A (1977) 1.49
Surface sialic acid reduces attachment of metastatic tumour cells to collagen type IV and fibronectin. Nature (1982) 1.48
Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer (1979) 1.48
Further evidence for depression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines. Nature (1976) 1.45
Immune responses against native and chemically modified albumins in mice. I. Analysis of non-thymus-processed (B) and thymus-processed (T) cell responses against methylated bovine serum albumin. J Exp Med (1972) 1.45
Antitumor effects of interferon preparations in mice. J Natl Cancer Inst (1970) 1.43
EGF receptor in neoplasia and metastasis. Cancer Metastasis Rev (1993) 1.43
H-2-like specificities of foreign haplotypes appearing on a mouse sarcoma after vaccinia virus infection. Nature (1976) 1.43
Interferon and murine leukemia. I. Inhibitory effect of interferon preparations on development of friend leukemia in mice. Proc Soc Exp Biol Med (1967) 1.43
Identification of the cell multiplication inhibitory factors in interferon preparations as interferons. Nature (1976) 1.41
Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals. J Immunol (1988) 1.39
Differential effects of interferon on the expression of H-2K, H-2D, and Ia antigens on mouse lymphocytes. J Immunol (1977) 1.38
Determination of antibody class in a system of cooperating antigenic determinants. J Exp Med (1970) 1.36
Interferon and cell division. IX. Interferon-resistant L1210 cells: characteristics and origin. J Natl Cancer Inst (1974) 1.36
Interferon messenger RNA is produced constitutively in the organs of normal individuals. Proc Natl Acad Sci U S A (1987) 1.36
Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A (1981) 1.34
Immune responses against native and chemically modified albumins in mice. II. Effect of electric charge and conformation on the humoral antibody response and on helper T cell responses. J Immunol (1974) 1.31
Anti-CD2 antibodies induce T cell unresponsiveness in vivo. J Exp Med (1991) 1.29
Interferon induces peripheral lymphadenopathy in mice. J Immunol (1981) 1.29
Electrophoretically pure mouse interferon exerts multiple biologic effects. Proc Natl Acad Sci U S A (1979) 1.28
Interferon enhances the excitability of cultured neurones. Nature (1979) 1.28
Microvascular injury in pathogenesis of interferon-induced necrosis of subcutaneous tumors in mice. J Natl Cancer Inst (1989) 1.27
Interactions of Fc receptors with antibodies against Ia antigens and other cell surface components. J Exp Med (1975) 1.27
Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res (1985) 1.27
Virus-specific interferon action. Protection of newborn Mx carriers against lethal infection with influenza virus. J Exp Med (1981) 1.24
Electrophoretically pure mouse interferon inhibits growth, induces liver and kidney lesions, and kills suckling mice. Am J Pathol (1981) 1.24
Different patterns of lectin binding and cell surface sialylation detected on related high- and low-metastatic tumor lines. Cancer Res (1983) 1.24
Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors. J Exp Med (1983) 1.22
Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective anti-tumor immunity in vivo and of cytolytic T cells in vitro. Int J Cancer (1979) 1.20
Efficacy of exogenous interferon treatment initiated after onset of multiplication of vesicular stomatitis virus in the brains of mice. J Gen Virol (1975) 1.19
Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon. J Exp Med (1980) 1.19
Interferon and cell division. II. Influence of various experimental conditions on the inhibition of L1210 cell multiplication in vitro by interferon preparations. J Natl Cancer Inst (1970) 1.19
Mechanism of the antitumour effect of interferon in mice. Nature (1972) 1.17
Nitric-oxide-induced apoptosis in human leukemic lines requires mitochondrial lipid degradation and cytochrome C release. Blood (1999) 1.17
Antitumor effects of interferon. Adv Cancer Res (1972) 1.16
The role of interferon in the resistance of C57BL/6 mice to various doses of herpes simplex virus type 1. J Infect Dis (1982) 1.16
Immediate effects of reversible HTLV-1 tax function: T-cell activation and apoptosis. Oncogene (1995) 1.16
Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons. J Gen Virol (1987) 1.14
Biological activities and receptor binding of two human recombinant interferons and their hybrids. J Gen Virol (1986) 1.14
Enhancement by interferon of natural killer cell activity in mice. Cell Immunol (1979) 1.14
The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg (1993) 1.11
A new sensitive assay for antibody against cell surface antigens based on inhibition of cell-dependent antibody-mediated cytotoxicity. I. Specificity and sensitivity. J Exp Med (1974) 1.11
Characterization and isolation of a trypsin-like serine protease from a long-term culture cytolytic T cell line and its expression by functionally distinct T cells. J Immunol (1986) 1.11
Specific high-affinity binding of 125I-labeled mouse interferon to interfevon resistant embryonal carcinoma cells in vitro. Virology (1981) 1.10
Inhibitory effect of interferon preparations and inducers on the multiplication of transplanted allogeneic spleen cells and syngeneic bone marrow cells. Nat New Biol (1973) 1.10
Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. Eur J Immunol (2000) 1.10
Effective subunit vaccines against an enveloped animal virus. Nature (1978) 1.10
Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes. Int J Cancer (1979) 1.10
Increased survival in mice inoculated with tumor cells and treated with interferon preparations. Proc Natl Acad Sci U S A (1969) 1.10
Heat-stable antigen (CD24) as ligand for mouse P-selectin. Int Immunol (1994) 1.09
Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its highly metastatic variant. Eur J Immunol (1982) 1.09
Antigenic variation in cancer metastasis: immune escape versus immune control. Cancer Metastasis Rev (1982) 1.09